Source: American Heart Journal. Unidades: FM, FMRP
Subjects: ANGIOPLASTIA, ISQUEMIA, CIRURGIA, PERNA, ESTUDOS MULTICÊNTRICOS, ARTÉRIA POPLÍTEA, COMPLICAÇÕES PÓS-OPERATÓRIAS
ABNT
BIAGIONI, Rodrigo Bruno et al. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American Heart Journal, v. 227, p. 100-106, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2020.06.010. Acesso em: 16 nov. 2024.APA
Biagioni, R. B., Lopes, R. D., Agati, L. B., Sacilotto, R., Wolosker, N., Sobreira, M. L., et al. (2020). Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American Heart Journal, 227, 100-106. doi:10.1016/j.ahj.2020.06.010NLM
Biagioni RB, Lopes RD, Agati LB, Sacilotto R, Wolosker N, Sobreira ML, Soares BL de F, Joviliano EE, Bernardi WH, Castelli Junior V, Caffaro RA, Fioranelli A, Bellen BV, Casella IB, Fidelis RJR, Flumignan RLG, Comerota AJ, Ramacciotti E. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial [Internet]. American Heart Journal. 2020 ; 227 100-106.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ahj.2020.06.010Vancouver
Biagioni RB, Lopes RD, Agati LB, Sacilotto R, Wolosker N, Sobreira ML, Soares BL de F, Joviliano EE, Bernardi WH, Castelli Junior V, Caffaro RA, Fioranelli A, Bellen BV, Casella IB, Fidelis RJR, Flumignan RLG, Comerota AJ, Ramacciotti E. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial [Internet]. American Heart Journal. 2020 ; 227 100-106.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ahj.2020.06.010